Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Buchert

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Anticancer Research|November 11, 2006
Visualisation of neuroblastoma growth in a Scid mouse model using [18F]FDG and [18F]FLT-PETNina Krieger-Hinck, Heike Gustke, Ursula Valentiner, et al.
Nuklearmedizin. Nuclear Medicine|June 24, 2026
On the utility of ChatGPT in conducting a literature review on deep learning for dopamine transporter SPECT with [¹²³I]ioflupaneThomas Buddenkotte, Ivayla Ilieva Apostolova, Roland Opfer, et al.
Annals of Nuclear Medicine|June 10, 2011
Quantification of [18F]-FDG uptake in atherosclerotic plaque: impact of renal functionThorsten Derlin, Christian R Habermann, Jasmin D Hahne, et al.
Nuklearmedizin. Nuclear Medicine|April 2, 2026
Difficult-to-interpret dopamine transporter SPECT with [123I]ioflupane in the diagnosis of parkinsonismIvayla Ilieva Apostolova, Thomas Buddenkotte, Loren Jedid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2006
Is correction for age necessary in SPECT or PET of the central serotonin transporter in young, healthy adults?Ralph Buchert, Oliver Schulze, Florian Wilke, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 11, 2010
Blood-brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controlsAnnemarie Goldbecker, Ralph Buchert, Georg Berding, et al.
Computers in Biology and Medicine|October 18, 2024
Higher effect sizes for the detection of accelerated brain volume loss and disability progression in multiple sclerosis using deep-learningRoland Opfer, Tjalf Ziemssen, Julia Krüger, et al.
Addiction Biology|June 20, 2024
Correlation of striatal dopamine D2/3 receptor availability with GABA level in the anterior cingulate cortex in healthy controls but not in alcohol-dependent subjects and individuals at high risk: A multimodal magnetic resonance spectroscopy and positron emission tomography studyGianna Spitta, Tobias Gleich, Annika Rosenthal, et al.
Neuroimage|January 8, 2010
B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysisFabian Wenzel, Stewart Young, Florian Wilke, et al.
Clinical Nuclear Medicine|January 10, 2022
Brain FDG PET for Short- to Medium-Term Prediction of Further Cognitive Decline and Need for Assisted Living in Acutely Hospitalized Geriatric Patients With Newly Detected Clinically Uncertain Cognitive ImpairmentCatharina Lange, Anja Mäurer, Per Suppa, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Anticancer Research|November 11, 2006
Visualisation of neuroblastoma growth in a Scid mouse model using [18F]FDG and [18F]FLT-PETNina Krieger-Hinck, Heike Gustke, Ursula Valentiner, et al.
Nuklearmedizin. Nuclear Medicine|June 24, 2026
On the utility of ChatGPT in conducting a literature review on deep learning for dopamine transporter SPECT with [¹²³I]ioflupaneThomas Buddenkotte, Ivayla Ilieva Apostolova, Roland Opfer, et al.
Annals of Nuclear Medicine|June 10, 2011
Quantification of [18F]-FDG uptake in atherosclerotic plaque: impact of renal functionThorsten Derlin, Christian R Habermann, Jasmin D Hahne, et al.
Nuklearmedizin. Nuclear Medicine|April 2, 2026
Difficult-to-interpret dopamine transporter SPECT with [123I]ioflupane in the diagnosis of parkinsonismIvayla Ilieva Apostolova, Thomas Buddenkotte, Loren Jedid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2006
Is correction for age necessary in SPECT or PET of the central serotonin transporter in young, healthy adults?Ralph Buchert, Oliver Schulze, Florian Wilke, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 11, 2010
Blood-brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controlsAnnemarie Goldbecker, Ralph Buchert, Georg Berding, et al.
Computers in Biology and Medicine|October 18, 2024
Higher effect sizes for the detection of accelerated brain volume loss and disability progression in multiple sclerosis using deep-learningRoland Opfer, Tjalf Ziemssen, Julia Krüger, et al.
Addiction Biology|June 20, 2024
Correlation of striatal dopamine D2/3 receptor availability with GABA level in the anterior cingulate cortex in healthy controls but not in alcohol-dependent subjects and individuals at high risk: A multimodal magnetic resonance spectroscopy and positron emission tomography studyGianna Spitta, Tobias Gleich, Annika Rosenthal, et al.
Neuroimage|January 8, 2010
B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysisFabian Wenzel, Stewart Young, Florian Wilke, et al.
Clinical Nuclear Medicine|January 10, 2022
Brain FDG PET for Short- to Medium-Term Prediction of Further Cognitive Decline and Need for Assisted Living in Acutely Hospitalized Geriatric Patients With Newly Detected Clinically Uncertain Cognitive ImpairmentCatharina Lange, Anja Mäurer, Per Suppa, et al.
Pageof 18